Navigation Links
Global CEO Initiative on Alzheimer's Disease (CEOi) Commits Industry to Innovation and Leadership in the Global Fight Against Alzheimer's and Dementia
Date:5/1/2013

General Manager of Health Sciences, Oracle
  • Robert Hormats , Under Secretary, Economic Growth, Energy, and the Environment, U.S. Department of State
  • Sue Siegel , CEO, healthymagination, GE
  • George Vradenburg , Convener, The Global CEO Initiative on Alzheimer's Disease
  • Anne Whitaker , President, North America Pharmaceuticals, Sanofi
  • Cecilia Arradaza , Director, Communications and Policy, FasterCures (moderator)
  • "Alzheimer's is one of the seminal public health issues of our time; the fiscal and social implications cannot be ignored," said Anne Whitaker , President, North America Pharmaceuticals, Sanofi. "From a health perspective and a business perspective, our only option is to pursue a comprehensive framework that includes partnerships, research investments, business models and policy changes to turn this pending crisis into opportunity."

    Alzheimer's and dementia is a global public health priority that requires a global solution.  According to the World Health Organization and the Alzheimer's Disease International 2012 Dementia Report, in 2010, there were approximately 36 million people worldwide suffering from dementia – most diagnosed over the age of 60 – and that number will spike to 115 million by 2050.  Further, the total worldwide costs of dementia, including Alzheimer's disease, were estimated to exceed $600 billion, which is equivalent to one percent of global gross domestic product (GDP).  Combined with a lack of treatment options and the aging of the global population, both prevalence and cost will skyrocket without proper attention and investment.   

    "CEOi intends to utilize our collective expertise across the health, diagnostic, medical, financial services and t
    '/>"/>

    SOURCE The Global CEO Initiative on Alzheimer’s Disease (CEOi)
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
    2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
    3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
    4. StemCyte Adds World Class Talent to its North America and Global Operations
    5. Sequenom Named to NASDAQ Global Select Market
    6. Synthetic Biology: Emerging Global Markets
    7. MacroGenics Receives Milestone Payment as Part of Its Global DARTâ„¢ Alliance with Boehringer Ingelheim
    8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
    9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
    10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
    11. Accuray Surpasses 600 Installations Globally
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... 23, 2014 On Friday, December ... 83, the Omnibus and Continuing Resolution Appropriations Act ... hydrocephalus a condition eligible to receive funding through ... by the Department of Defense (DoD). The Hydrocephalus ... on Capitol Hill, is celebrating this victory for ...
    (Date:12/24/2014)... 23, 2014 Pipette.com announces their ... followers can submit their #HolidayInTheLab pictures for a chance ... mates. , For those struggling to think of a ... Holiday in the Lab Contest provides the ideal holiday ... to send pictures of their chemistree, holiday sweaters, ...
    (Date:12/24/2014)... 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... a Clinical Trial Application (CTA) with the ... (MHRA) seeking regulatory approval to initiate clinical trials for ... Contingent on the Company receiving CTA regulatory ... trial to assess the safety, tolerability and dose escalation ...
    (Date:12/22/2014)... N.C. , Dec. 22, 2014  Alternative ... announced that it has signed a letter of ... that has developed and patented a nanotechnology-based development ... diagnostics products that enable rapid on-site collection and ... use/abuse and health issues in an immediate, non-invasive ...
    Breaking Biology Technology:Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3ALNE Announces Intention To Acquire BioTechPharma 2
    ... 16 BioEnergy International, ... of next-generation, renewable biochemicals and biofuels, announces the ... all of its biobased chemicals business and intellectual ... biofuels opportunities, including its 110 million gallon per ...
    ... June 16 Wyeth (NYSE: WYE ) (the ... Senior Debentures due 2024 (the "Convertible Debentures") have the right ... to their terms effective on the July 15, 2009 purchase ... in aggregate principal amount of Convertible Debentures outstanding. , ...
    ... Wound Care Innovations, LLC, a subsidiary of Wound ... reached an agreement in principle to acquire BioPharma Management ... platform of proprietary and patented technologies for topical pain ... structured as a share exchange pursuant to which BioPharma ...
    Cached Biology Technology:BioEnergy International, LLC Announces Formation of Myriant Technologies LLC 2Wyeth Announces Holder Right to Surrender Convertible Debentures 2Wyeth Announces Holder Right to Surrender Convertible Debentures 3Wyeth Announces Holder Right to Surrender Convertible Debentures 4Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc. 2
    (Date:12/19/2014)... , Dec. 18, 2014 Research and Markets ... of the "Micro Market Monitor: North America Perimeter ... http://photos.prnewswire.com/prnh/20130307/600769 The ... at a CAGR of 3.6% from 2014 to 2019. ... this market, Canada is expected ...
    (Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
    (Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
    Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
    ... recent study led by scientists from the National University of ... Spinal Muscular Atrophy (SMA), a devastating disease that is the ... young adults. As there is currently no known cure for ... fight against SMA. SMA is caused by deficiencies ...
    ... , Dec. 18, 2013 Tissue engineering ... a regenerative or reparative medicine with potential to ... engineering, which involve leveraging technologies from biomaterials, molecular ... the restructure and/or repair of human organs through ...
    ... have shown for the first time that the specialised role ... cilia tiny hair-like structures protruding from a cell. Stem ... body through the process of differentiation. The discovery ... therapies for a range of medical treatments where scientists aim ...
    Cached Biology News:Study led by NUS scientists provides new insights into cause of human neurodegenerative disease 2Study led by NUS scientists provides new insights into cause of human neurodegenerative disease 3State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 2State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 3State-of-the-Art Tissue Engineering and Organ Regeneration Technologies Yield Healthcare Market Disruption 4
    Template and primers for preparation of internal control spots...
    Template and primers for preparation of internal control spots...
    ANTI FLAG EP CL VEC...
    RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
    Biology Products: